Nucleoside analogs and oligonucleotide derivatives containing these analogs
Nucleoside analogues expressed by the following general formula where B represents an aromatic base having carbonyl oxygen at the 2-position, or a 2-hydroxyphenyl group, or oligonucleotide derivatives containing one or more of the nucleoside analogues are provided. The oligonucleotide derivatives are triplex-forming oligonucleotide derivatives which bind specifically to target double-stranded DNA with high affinity in the antigene method to form triplexes, and can thereby control and inhibit the expression of relevant genes efficiently, and which show high resistance to nucleases.
1. Nucleoside analogues expressed by the following general formula (I)
where B represents a substituent selected from substituents expressed by the following general formulas
where J, K, L and Q are identical or different, and each denote —H, a lower alkyl, —OH, or —NH 2 , 1, m and p independently denote an integer of 1 to 4, and n denotes an integer of 1 or 2,
X and Y are identical or different, and each represent hydrogen, an alkyl group, an alkenyl group, an alkinyl group, a cycloalkyl group, an aralkyl group, an aryl group, an acyl group, or a silyl group,
or amidite derivatives thereof.
2. Nucleoside analogues or amidite derivatives thereof according to claim 1 , wherein B represents a substituent expressed by any one of the following general formulas
where J, K, L, l, m, X and Y are as defined above.
3. Nucleoside analogues or amidite derivatives thereof according to claim 1 , wherein B represents a substituent expressed by the following general formula
where Q, p, X and Y are as defined above.
4. Nucleoside analogues according to claim 1 , 2 or 3 , wherein X and Y are each hydrogen.
5. Amidite derivative according to claim 1 , 2 or 3 , wherein X is 4,4′-dimethoxytrityl (DMTr), and Y is a 2-cyanoethoxy(diisopropylamino)phosphino group (amidite group).
6. Nucleoside analogues according to claim 1 or 2 , wherein B is a substituted or unsubstituted 2-oxopyridyl or a substituted or unsubstituted isoquinoline.
7. Nucleoside analogues according to claim 6 , wherein B is selected from 2-oxopyridyl, 5-methyl-2-oxopyridyl, 4-hydroxy-2-oxopyridyl, and isoquinolin-1-one.
8. Nucleoside analogues according to claim 7 , wherein B is 2-oxopyridyl.
9. Nucleoside analogues according to claim 1 or 3 , wherein B is 2-hydroxyphenyl.
10. Oligonucleotide or polynucleotide derivatives having one or more of the nucleoside analogues according to any one of claims 1 to 3 .